UBS O'Connor’s OrthoPediatrics KIDS Stock Holding History
Bought
Maintained
Sold
Other funds holding KIDS
B
BCM
GIM
UBS O'Connor's KIDS Position: Q3 2025 in Review
UBS O'Connor sold out of OrthoPediatrics (KIDS) in Q3 2025, closing a stake of 65,866 shares — an estimated $1.41M sold.
UBS O'Connor first reported a position in KIDS in Q2 2022 and held it in 12 quarters. The position peaked at $2.2M in Q1 2023. 111 funds tracked by Wall St. Rank hold KIDS as of Q3 2025.
- UBS O'Connor reported no remaining OrthoPediatrics position as of Q3 2025 after selling out during the quarter.
- UBS O'Connor sold 65,866 OrthoPediatrics shares in Q3 2025, an estimated $1.41M.
- UBS O'Connor first reported a position in OrthoPediatrics in Q2 2022 and held it in 12 quarters.
- UBS O'Connor's OrthoPediatrics position peaked at $2.2M in Q1 2023.
- 111 funds tracked by Wall St. Rank held OrthoPediatrics as of Q3 2025.
Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.